4 Big Banks Still Valued at or Under Book Value After Earnings Gains

Earnings season for the fourth quarter is bringing some very mixed fanfare for investors at a time when economic numbers are slowing and earnings growth is expected to be easing. ...
Read Full Story »

Ford Exits Detroit Car Show in More Trouble Than When It Went In

The North American International Auto Show in Detroit is one of the world's largest venues for manufacturers to launch new cars and for industry CEOs to explain their visions for ...
Read Full Story »

Goldman Sachs Surges as Best Performing Dow Stock

What a difference a year makes. In 2018, Goldman Sachs Group Inc. (NYSE: GS) was among the worst performing stock among the components of the Dow Jones industrial average. So ...
Read Full Story »

Budget Airlines With the Best On-Time Record

Two of the most important factors when booking a flight is the price and the airline’s reputation, specifically its track record for on time departures and arrivals. Ideally, a traveller ...
Read Full Story »

Friday’s Biggest Winners and Losers in the S&P 500

January 18, 2019: The S&P 500 closed up 1.4% at 2,672.89. The DJIA closed up 1.5% at 24,727.50. Separately, the Nasdaq closed up 1.0% at 7,157.23. Friday was a positive ...
Read Full Story »

Players With the Most Super Bowl Rings

The ultimate goal of every NFL team is to win the Super Bowl. The legacies of great players are defined by the titles they won, or lost. Many players can ...
Read Full Story »

The Price of a Cup of Coffee Around the World

Americans are setting records when it comes to drinking coffee. Nearly 65% of adults in the country have at least one cup of coffee every day, an increase from 62% ...
Read Full Story »

Immunomedics, Nautilus Sink Into Friday’s 52-Week Low Club

January 18, 2019: Here are four stocks trading with heavy volume among 20 equities that have posted new 52-week lows by the noon hour Friday. On the New York Stock ...
Read Full Story »

FDA Diabetes Treatment Vote to Determine the Fate of Lexicon Therapeutics?

Lexicon Pharmaceutics Inc. (NASDAQ: LXRX) shares fell on Friday after the U.S. Food and Drug Administration (FDA) voted to approve the firm’s type 1 diabetes treatment. Although the result from ...
Read Full Story »

The Fastest Growing and Shrinking States

Long-term population decline can spell disaster for any economy. A shrinking population can result in labor shortages, lower tax revenue, higher per-capita debt, and weakened GDP growth. While the U.S. ...
Read Full Story »

January Consumer Sentiment Index Plunges

The preliminary University of Michigan Consumer Sentiment Index for January tumbled month over month from a final December reading of 98.3 to January's level of 90.7. The January reading may ...
Read Full Story »

11 US Natural Disasters Last Year Each Caused Over $1 Billion in Damages

Compared to 2017, last year's estimate for natural disasters causing more than $1 billion in damages appears to be a big improvement. There were 11 events in 2018 that caused ...
Read Full Story »

Is Immunomedics Breast Cancer Treatment Doomed After This FDA Update?

Immunomedics Inc. (NASDAQ: IMMU) shares were crushed on Friday after the firm received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA). Usually, CRLs can spell ...
Read Full Story »

Outlook for 2019 Oil Market ‘Not Very Cheerful’: IEA

In its monthly Oil Market Report for January released Friday morning, the International Energy Agency (IEA) said that global crude supplies dropped by 950,000 barrels a day to total 100.6 ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BofA, Caterpillar, Chevron, CSX, Kimberly-Clark, Nautilus, Netflix, Signet, Valero and More

Stocks were indicated to open higher on renewed trade hopes on Friday. Still, the Dow Jones industrials had rebounded more than 1,500 points from the lows of January 3. Investors have ...
Read Full Story »